Group 1 - The core point of the news is that Hanyi Pharmaceutical (430478) experienced significant trading activity on July 30, 2025, with a turnover rate of 30.88% and a transaction volume of 14.58 million shares, amounting to 359 million yuan [1][2][3] - The top buying seat was an institutional account, purchasing approximately 7.25 million yuan worth of shares, while the top selling seat was CITIC Securities, selling approximately 7.41 million yuan [1][2] - The trading data indicates a high level of interest in Hanyi Pharmaceutical, as evidenced by the substantial turnover and the involvement of institutional investors [1][2] Group 2 - The detailed trading data shows various brokerage firms involved in both buying and selling activities, with significant amounts traded by multiple accounts [2] - The buying and selling amounts from different brokerage firms highlight the competitive nature of the trading environment for Hanyi Pharmaceutical [2] - The presence of institutional investors in the buying activity suggests a potential positive outlook for the company among professional market participants [1][2]
机构席位买入724.67万 北交所上市公司峆一药业登龙虎榜